[Pericardial involvement in Hodgkin's disease]

Area of Science:

• Cardiology
• Oncology
• Hematology

Background:

• Hodgkin's disease (HD) is a cancer of the lymphatic system.
• Pericardial effusion (PE) is the abnormal accumulation of fluid around the heart.
• The relationship between HD, mediastinal mass, and PE requires further investigation.

Purpose of the Study:

• To investigate the incidence and characteristics of pericardial effusion in patients with newly diagnosed Hodgkin's disease.
• To correlate pericardial effusion with clinical stage, mediastinal mass size, and T lymphocyte counts.
• To assess the impact of polychemotherapy on pericardial effusion in HD patients.

Main Methods:

• Echocardiographic examinations were performed before and after polychemotherapy in 21 consecutive Hodgkin's disease patients.
• Clinical staging, mediastinal mass assessment, and T lymphocyte counts were analyzed.
• Comparison was made between patients with and without pericardial effusion.

Main Results:

• Five patients (24%) developed pericardial effusion, with one showing epicardial infiltrate.
• Patients with PE had advanced clinical stages (IVB, IIIB) and significantly larger mediastinal masses compared to those without PE.
• A statistically significant decrease in T lymphocytes was observed in the PE group.

Conclusions:

• Pericardial effusion in Hodgkin's disease is associated with advanced disease, larger mediastinal tumors, and compromised T lymphocyte levels.
• The resolution of PE after chemotherapy suggests it is a manifestation of the underlying disease rather than an independent cause.
• Echocardiography is valuable for detecting and monitoring cardiac involvement in Hodgkin's disease.